AriBioLab Co.,Ltd. (KOSDAQ:261780)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,595.00
+130.00 (5.27%)
At close: Sep 3, 2026

AriBioLab Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-14,420-16,044-10,138-1,749-6,715-18,420
Depreciation & Amortization
418.58455.64491.22533.31417.36245.49
Loss (Gain) From Sale of Investments
-3.07-263.18-66.7740.4-105.84-125.77
Stock-Based Compensation
-12.1368.761.53118.92444.39451.81
Other Operating Activities
2,9353,7083,789-2,2861,24012,783
Change in Other Net Operating Assets
1,9081,059-2,232-1,951-469.56325.6
Operating Cash Flow
-9,173-11,017-8,096-5,293-5,189-4,740
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-31.74-116.84-179.21-278.58-447.4-679.57
Sale of Property, Plant & Equipment
0.880.88----
Sale (Purchase) of Intangibles
-10.92-39.08-55.37-12.21--3.66
Investment in Securities
20,83615,8382,64822,2214,184-46,780
Other Investing Activities
48.634.65-121.79--0-
Investing Cash Flow
20,84215,7182,29121,9303,736-47,463

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--10,00010,000--
Total Debt Issued
4,000-10,00010,000--
Long-Term Debt Repaid
--5,105-209.64-23,671-116.29-116.29
Total Debt Repaid
-15,919-5,105-209.64-23,671-116.29-116.29
Net Debt Issued (Repaid)
-11,919-5,1059,790-13,671-116.29-116.29
Issuance of Common Stock
3,10387.38199.9554.71-44,436
Other Financing Activities
---0-0--
Financing Cash Flow
-8,816-5,0189,990-13,117-116.2944,320

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-----0.17
Miscellaneous Cash Flow Adjustments
---0-0--
Net Cash Flow
2,853-317.264,1863,520-1,568-7,883

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-9,205-11,134-8,275-5,572-5,636-5,419
Free Cash Flow Growth
------
Free Cash Flow Margin
-5315.64%-7019.41%-2232.46%-1894.38%-3140.08%-1083.83%
Free Cash Flow Per Share
-342.30-414.59-308.52-210.20-213.18-232.41
Levered Free Cash Flow
-6,980-5,931-2,183-10,251-6,799-6,029
Unlevered Free Cash Flow
-5,884-4,586-1,378-8,607-5,195-4,703

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
--64.87-168.01288.6585.9717.07
Change in Working Capital
1,9081,059-2,232-1,951-469.56325.6